About IMMUNYX PHARMA USA INC.
Immunyx is a drug development company focused on neutrophil modulation in disease, aiming to develop effective and safe treatments for chronic conditions such as COPD, cancer, colitis, and arthritis. The company uses novel pharmacological approaches to modulate neutrophil toxicity.
Is this your company?
Claim IMMUNYX PHARMA USA INC. to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim IMMUNYX PHARMA USA INC. & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.